EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clonal hematopoiesis and risk of nonmyeloid subsequent malignant neoplasms after autologous hematopoietic cell transplantation

June-Wha Rhee iD, Sitong Chen, Raju Pillai iD, Alysia Bosworth iD, Artem Oganesyan iD, Emma Grigorian iD, Liezl Atencio, Caitlyn Estrada iD, Mareen Kassabian, Lanie Lindenfeld, Rusha Bhandari iD, Scott Goldsmith iD und 7 weitere

JNCI: Journal of the National Cancer Institute · 2025

DOI: 10.1093/jnci/djaf181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von June-Wha Rhee und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, United States. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Hematopoietic Stem Cell Transplantation, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: V Foundation for Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The association between clonal hematopoiesis (CH) and nonmyeloid subsequent malignant neoplasms (SMNs) after autologous hematopoietic cell transplantation (HCT) has not been explored.

Methods

This was a retrospective cohort study of 1931 consecutive patients who underwent HCT between 2010 and 2016 at a single center. DNA from pre-HCT mobilized blood products was sequenced to identify CH variants (variant allele frequency [VAF] ≥2%). The primary outcome was 8-year(y) cumulative incidence of nonmyeloid SMNs. Multivariable regression analysis was used to evaluate the association between CH and nonmyeloid SMNs, as well as cause-specific mortality.

Results

Median age at HCT was 58.8 y (range = 18.4-78.1 y); 389 patients (20.1% of the cohort) had at least 1 CH variant and 94 (4.9%) had ≥2 variants. The 8 y cumulative incidence of nonmyeloid SMNs was significantly higher in patients with CH compared with those without (15.1% vs 7.2%, P < .001), and increased by VAF: 7.2% (VAF <2%), 14.0% (VAF 2% to <10%), 19.4% (VAF ≥10%); P = .001. Patients with CH had a 2-fold increased risk of nonmyeloid SMNs (standardized incidence ratio = 1.9), compared with the general population. In multivariable analysis, CH was an independent and significant risk factor for nonmyeloid SMNs (hazard ratio [HR] = 1.72, 95% confidence interval [CI] = 1.15 to 2.59). Finally, patients with CH had significantly worse survival, primarily due to the higher risk of nonrelapse mortality (HR = 2.97, 95% CI = 1.90 to 4.64).

Conclusions

CH was significantly associated with the risk of nonmyeloid SMNs after HCT, and the magnitude of association increased by VAF. Clonal hematopoiesis may serve as a biomarker for identifying HCT survivors at higher risk for developing nonmyeloid SMNs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisHematopoietic Stem Cell TransplantationNeoplasmsTransplantation, AutologousRetrospective StudiesIncidenceHumansAdolescentYoung AdultAdultMiddle AgedAgedHigh-Throughput Nucleotide SequencingMaleFemale

Autor:innen und Institutionen

  • Department of Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
  • Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
  • Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
  • Department of Hematology & Hematopoietic Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.

ORCID-Profile: June-Wha Rhee, Raju Pillai, Alysia Bosworth, Artem Oganesyan, Emma Grigorian, Caitlyn Estrada, Rusha Bhandari, Scott Goldsmith, Matthew G Mei, F Lennie Wong, Saro H Armenian

Förderung

  • V Foundation for Cancer Research

Zitieren

APA

Rhee, J. W., Chen, S., Pillai, R., Bosworth, A., Oganesyan, A., Grigorian, E., Atencio, L., Estrada, C., Kassabian, M., Lindenfeld, L., Bhandari, R., Goldsmith, S., Rosenzweig, M., Herrera, A. F., Mei, M. G., Nakamura, R., Lennie Wong, F., Forman, S. J., & Armenian, S. H. (2025). Clonal hematopoiesis and risk of nonmyeloid subsequent malignant neoplasms after autologous hematopoietic cell transplantation. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf181

Vancouver

Rhee JW, Chen S, Pillai R, Bosworth A, Oganesyan A, Grigorian E, et al. Clonal hematopoiesis and risk of nonmyeloid subsequent malignant neoplasms after autologous hematopoietic cell transplantation. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djaf181

BibTeX
@article{Rhee2025,
  author = {Rhee, June-Wha and Chen, Sitong and Pillai, Raju and Bosworth, Alysia and Oganesyan, Artem and Grigorian, Emma and Atencio, Liezl and Estrada, Caitlyn and Kassabian, Mareen and Lindenfeld, Lanie and Bhandari, Rusha and Goldsmith, Scott and Rosenzweig, Michael and Herrera, Alex F and Mei, Matthew G and Nakamura, Ryotaro and Lennie Wong, F and Forman, Stephen J and Armenian, Saro H},
  title = {Clonal hematopoiesis and risk of nonmyeloid subsequent malignant neoplasms after autologous hematopoietic cell transplantation},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2025},
  doi = {10.1093/jnci/djaf181}
}
Kostenlos starten →